HeartMate left ventricular assist system exchange: Results and technical considerations

ASAIO Journal

Volumn 55, Issue 6, 2009, Pages 598-601

  Adamson, Robert M ^a   Dembitsky, Walter P ^a   Baradarian, Sam ^a   Chammas, Joseph ^a   Jaski, Brian ^a   Hoagland, Peter ^a   McCalmont, Vicki ^a   Ortiz, Kristi ^a   Stahovich, Marsha ^a   Chillcott, Suzanne ^a  

^a SHARP MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE DEVICES; BEARING FAILURES; DESTINATION THERAPY; ELECTRIC PUMPS; KAPLAN-MEIER; LEFT VENTRICULAR ASSIST DEVICES; LEFT VENTRICULAR ASSIST SYSTEMS; MEAN AGES; MORTALITY RATE; OVERALL SURVIVAL; WAIT TIME;

PUMPS;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SURGERY; DEVICE REMOVAL; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART VENTRICLE; HUMAN; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; STATISTICS; TIME;

ADULT; AGED; CARDIOVASCULAR SURGICAL PROCEDURES; DEVICE REMOVAL; FEMALE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; TIME;

EID: 73949129448     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3181bd446a     Document Type: Article

References (14)

1. Frazier OH, Rose EA, Oz MC, et al: Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 122: 1186-1195, 2001.
2. Rose EA, Moskowitz AJ, Packer M, et al: The REMATCH trial: rationale, design, and end points. randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg 67: 723-730, 1999.
3. Rose EA, Gelijns AC, Moskowitz AJ, et al: Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345: 1435-1443, 2001.
4. Dowling RD, Park SJ, Pagani FD, et al: HeartMate VE LVAS design enhancements and its impact on device reliability. Eur J Cardiothorac Surg 25: 958-963, 2004.
5. Pagani FD, Long JW, Dembitsky WP, et al: Improved mechanical reliability of the HeartMate XVE left ventricular assist system. Ann Thorac Surg 82: 1413-1418, 2006.
6. Martin J, Friesewinkel O, Benk C, et al: Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. J Heart Lung Transplant 25: 384-390, 2006.
7. Lietz K, Long JW, Kfoury AG, et al: Outcomes of left ventricular assist device implantation as destination therapy in the post- REMATCH era: implications for patient selection. Circulation 116: 497-505, 2007.
8. Jaski BE, Miller D, Hoagland P, et al: Assessment of recurrent heart failure during LVAD support due to inflow cannula dysfunction. J Heart and Lung Transplantation 24: 260-267, 2005.
9. Dembitsky WP, Tector AJ, Park S, et al: Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg 78: 2123-2129; discussion 2129-2130, 2004.
10. Gregoric ID, Myers TJ, Kar B, et al: Management of air embolism during HeartMate XVE exchange. Tex Heart Inst J 34: 19-22, 2007.
11. Horton SC, Khodaverdian R, Chatelain P, et al: Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol 45: 1435-1440, 2005.
12. Myers TJ, Palanichamy N, La Francesca S, et al: Management of multiple left ventricular assist device failures in a patient. J Heart Lung Transplant 26: 98-100, 2007. (Pubitemid 46096739)
13. Haft JW, Suzuki Y, Aaronson KD, et al: Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system. ASAIO J 53: 298-303, 2007.
14. Slaughter MS, Feldman CM, Sobieski MA, et al: Utilization of acoustic signatures to identify HeartMate XVE device end-oflife. J Heart Lung Transplant 26: 579-583, 2007.